Molecular Epidemiological Study of Nosocomial Enterobacter aerogenes Isolates in a Belgian Hospital
|
|
- Randall Logan
- 6 years ago
- Views:
Transcription
1 JOURNAL OF CLINICAL MICROBIOLOGY, July 1998, p Vol. 36, No /98/$ Copyright 1998, American Society for Microbiology. All Rights Reserved. Molecular Epidemiological Study of Nosocomial Enterobacter aerogenes Isolates in a Belgian Hospital SHEIKH JALALUDDIN, 1,2 JEANNE-MARIE DEVASTER, 1 ROBERT SCHEEN, 1 MICHELE GERARD, 3 AND JEAN-PAUL BUTZLER 1,2 * Department of Microbiology 1 and Infectious Diseases Department, 3 Saint-Pierre University Hospital, and Department of Molecular Microbiology, Free University of Brussels, 2 Brussels, Belgium Received 6 January 1998/Returned for modification 8 February 1998/Accepted 16 March 1998 In 1995, the rate of isolation of Enterobacter aerogenes in the Saint-Pierre University Hospital in Brussels, Belgium, was higher than that in the preceding years. A total of 45 nosocomial E. aerogenes strains were collected from 33 patients of different units during that year, and they were isolated from 19 respiratory specimens, 13 pus specimens, 7 blood specimens, 4 urinary specimens, 1 catheter specimen, and 1 heparin vial. The strains were analyzed to determine their epidemiological relatedness and were characterized by their antibiotic resistance pattern determination, plasmid profiling, and genomic fingerprinting by macrorestriction analysis with pulsed-field gel electrophoresis (PFGE). The majority of the strains (82%) were multiply resistant to different commonly used antibiotics. Two major plasmid profiles were found: most strains (64%) harbored two plasmids of different sizes, whereas the others (20%) contained a single plasmid. PFGE with SpeI and/or XbaI restriction enzymes revealed that a single clone (80%) was responsible for causing infections or colonizations throughout the year, and this result was concordant with those obtained by plasmid profiling, with slight variations. By comparing the results of these three methods, PFGE and plasmid profiling were found to be the techniques best suited for investigating the epidemiological relatedness of E. aerogenes strains, and they are therefore proposed as useful tools for the investigation of nosocomial outbreaks caused by this organism. The genus Enterobacter is one of the members of the family Enterobacteriaceae and consists of 13 species (8). Among them, Enterobacter cloacae and Enterobacter aerogenes are the most frequently isolated species, causing infections in hospitalized and debilitated patients (10, 29). In recent years, E. aerogenes has emerged as an important nosocomial bacterial pathogen (6, 20). The strains are usually characterized by their high levels of resistance to ampicillin, amoxicillin-clavulanic acid, and expanded-spectrum cephalosporins or imipenem (3, 14, 23, 25). E. aerogenes outbreaks are often found to occur among intensive care unit (ICU) patients, and colonization usually occurs in the respiratory, urinary, and gastrointestinal tracts and less frequently in skin and surgical wounds (1, 5, 7, 11, 21). Nosocomial bacterial infections are an important cause of morbidity and mortality in both developing and developed countries. Transmission of nosocomial outbreak-related bacteria may be effectively controlled by taking appropriate control measures. Before that is done, however, it may be necessary to identify a particular clone or clones of bacteria. The recognition that a single clone is spreading a number of infections is an essential early step in the investigation of a possible outbreak in a hospital. To do that, epidemiological typing of the strains is performed by using possible genotypic and phenotypic methods. Phenotypic techniques are insufficient for discriminating different isolates of Enterobacter spp. However, a number of genotype-based techniques have been successfully applied for demonstrating the differences between the strains (4, 11 13, 15). In 1995, the isolation rate of E. aerogenes in the Saint- Pierre University Hospital was higher than those in the preceding years and in the following year. To determine whether the strains were epidemiologically linked, we analyzed them by * Corresponding author. Mailing address: Department of Microbiology, Saint-Pierre University Hospital, Rue Haute 322, B-1000 Brussels, Belgium. Phone: Fax: jbutzler@ben.vub.ac.be. using biotyping, antibiotyping, plasmid profiling, and genomic fingerprinting by macrorestriction analysis with pulsed-field gel electrophoresis (PFGE). (This work was presented in part at the 97th General Meeting of the American Society for Microbiology, Miami Beach, Fla., 4 to 8 May 1997 [14a].) MATERIALS AND METHODS Bacterial strains: origin and identification. The Saint-Pierre University Hospital is a 450-bed teaching hospital located in the center of Brussels, Belgium. It has two ICUs (internal medicine and surgery) of 13 beds each and several departments. The 45 E. aerogenes strains were collected from 33 patients hospitalized in different wards, and their hospital records were reviewed by two investigators to confirm nosocomial acquisition according to the criteria of the Centers for Disease Control and Prevention (9). The strains were isolated from 19 (42.2%) respiratory specimens, 13 (28.9%) pus specimens, 7 (15.6%) blood specimens, 4 (8.9%) urinary specimens, 1 (2.2%) catheter specimen, and 1 (2.2%) heparin vial specimen. E. aerogenes isolates were primarily identified in the microbiology laboratory by standard culture techniques (8). Subsequently, the identities of the strains were confirmed by the BBL crystal E/NF identification system (Becton Dickinson, Cockeysville, Md.). This system provides the interpretation of the results of 30 different biochemical tests including a manual oxidase and indole tests. It is more reliable and cost-effective, can be performed more quickly and simply, and is safer to use than other commercially available microbial identification systems described in several reports (24, 28, 32). Screening of environmental specimens. Environmental specimens were screened for E. aerogenes by culturing premoistened swabs from the suspected surfaces and liquid samples obtained from different environmental sources or devices. The samples included swabs of the table surfaces near the infected or colonized patients (n 10), disinfectants when they were available at the bedside of the patients from ICUs and geriatric units (n 7), humidifying cascades from the mechanical ventilators of the patients admitted to the ICUs (n 15), oxygen humidifier bottles for nebulizers (n 5), tap water and hot and cold water faucets (n 5), and a heparin vial used for one patient admitted to an ICU (n 1). No specimens from the hands of the hospital personnel were available. Antibiotic susceptibility testing. Antimicrobial susceptibility testing was performed on Mueller-Hinton agar (Oxoid Ltd., Hampshire, United Kingdom) medium by a tablet disk diffusion method with Neo-sensitabs (Rosco Diagnostica, Taastrup, Denmark) against a panel of 14 antimicrobial drugs. Neo-sensitabs are produced according to the guidelines of the World Health Organization (33) and are standardized according to the MIC breakpoints recommended by the National Committee for Clinical Laboratory Standards (22). The zone sizes 1846
2 VOL. 36, 1998 MOLECULAR EPIDEMIOLOGY OF NOSOCOMIAL E. AEROGENES 1847 TABLE 1. Phenotypic and genotypic characters of E. aerogenes isolates isolated from patients in Saint-Pierre University Hospital in 1995 a Isolate no. Patient designation Strain identification Antimicrobial susceptibility b (antibiotype) Biotype c Plasmid profile d PFGE profile e SpeI XbaI 1 1 FH-49 Gm, SXT, AMC, PTZ, ATM, TEM, CTAZ, AK, CIP, IMP (6) 1 NP NC NC 2 2 FH-51 Gm, SXT, PTZ, ATM, TEM, CTAZ, CXM, CTX, AK, CIP, IMP (5) 1 C IIa IIa 3 2 FH-52 Gm, SXT, PTZ, ATM, TEM, CTAZ, CXM, CTX, AK, CIP, IMP (5) 1 C IIa IIa 4 2 BG-59 Gm, SXT, PTZ, ATM, TEM, CTAZ, CXM, CTX, AK, CIP, IMP (5) 13 C IIa IIa 5 3 FH-53 Gm, SXT, PTZ, ATM, TEM, CTAZ, CTX, AK, CIP, IMP (7) 2 B NC NC 6 4 FH-54 Gm, TEM, AK, IMP (1) 4 A I I 7 4 BG-60 Gm, TEM, AK, IMP (1) 14 A I I 8 5 FH-55 Gm, TEM, AK, IMP (1) 5 A I I 9 6 FH-56 Gm, TEM, AK, IMP (1) 12 A I I 10 7 FH-57 Gm, AMC, TEM, AK, IMP (2) 5 A I I 11 8 FH-58 Gm, AMC, TEM, AK, IMP (2) 6 A I I 12 8 BG-61 Gm, AMC, TEM, AK, IMP (2) 14 A I I 13 8 BG-63 Gm, AMC, TEM, AK, IMP (2) 7 A I I 14 9 FH-59 Gm, TEM, AK, IMP (1) 5 A I I FH-60 Gm, TEM, AK, IMP (1) 6 A I I FH-63 Gm, AMC, PTZ, TEM, AK, IMP (3) 3 A I I FH-64 Gm, TEM, AK, IMP (1) 7 B I I BG-62 Gm, TEM, AK, IMP (1) 7 A I I FH-65 Gm, AMC, TEM, AK, IMP (2) 4 A I I FH-67 Gm, AMC, PTZ, TEM, AK, IMP (3) 6 A I I FH-70 Gm, AMC, TEM, AK, IMP (2) 4 A I I FH-76 Gm, AMC, PTZ, TEM, AK, IMP (3) 4 A I I FH-71 Gm, AMC, TEM, AK, IMP (2) 4 A I I FH-74 Gm, AMC, PTZ, TEM, CTX, AK, IMP (4) 9 B I I FH-80 Gm, AMC, PTZ, TEM, CTX, AK, IMP (4) 4 A I I FH-81 Gm, AMC, PTZ, TEM, CTX, AK, IMP (4) 5 A I I FH-72 Gm, AMC, PTZ, TEM, CTX, AK, IMP (4) 8 A IIb IIb FH-73 Gm, AMC, PTZ, TEM, AK, IMP (3) 5 A I I FH-75 Gm, AMC, PTZ, TEM, CTX, AK, IMP (4) 5 B I I FH-77 Gm, SXT, AMC, TEM, AK, CIP, IMP (8) 3 NP NC NC FH-78 Gm, AMC, PTZ, TEM, CTX, AK, IMP (4) 5 B I I FH-85 Gm, AMC, PTZ, TEM, CTX, AK, IMP (4) 10 A I I FH-86 Gm, AMC, PTZ, CTX, AK, IMP (10) 5 A I I FH-79 Gm, AMC, PTZ, TEM, CTX, AK, IMP (4) 5 B I I FH-82 Gm, SXT, AMC, PTZ, ATM, TEM, CTAZ, CFZ, CXM, CTX, AK, CIP, IMP (9) 1 C IIa IIa FH-83 Gm, AMC, PTZ, TEM, CTX, AK, IMP (4) 10 A I I FH-84 Gm, AMC, PTZ, TEM, AK, IMP (3) 5 A I I FH-87 Gm, AMC, PTZ, TEM, AK, IMP (3) 3 B I I FH-88 Gm, AMC, PTZ, TEM, CTX, AK, IMP (4) 3 B I I FH-89 Gm, AMC, PTZ, TEM, CTX, AK, IMP (4) 9 A I I FH-90 Gm, SXT, AMC, PTZ, ATM, TEM, CTAZ, CTX, AK, CIP, IMP (11) 11 MP IIb IIb FH-91 Gm, AMC, PTZ, TEM, CTX, AK, IMP (4) 9 A I I FH-92 GM, AMC, PTZ, TEM, CTX, AK, IMP (4) 4 B I I BG-57 Gm, TEM, AK, IMP (1) 7 A I I BG-64 Gm, TEM, AK, IMP (1) 1 A I I a A total of 45 E. aerogenes isolates were obtained. b Susceptibility to different antimicrobial agents. Abbreviations are as follows: Gm, gentamicin; SXT, trimethoprim-sulfamethoxazole; AMC, amoxicillin-clavulanate; PTZ, piperacillin-tazobactam; ATM, aztreonam; TEM, temocillin; CTAZ, ceftazidime; CFZ, cefazolin; CXM, cefuroxime; AK, amikacin; CIP, ciprofloxacin; IMP, imipenem. c Biotypes are based on the different numerical profiles generated from the BBL Crystal E/NF system. d Plasmid profile A, 2 plasmids (30 to 40 and 5 to 6 MDa, respectively); profile B, one plasmid (5 to 6 MDa); profile C, three plasmids (20 to 30, 15 to 20, and 5 to 6 MDa, respectively); NP, no plasmid; MP, multiple plasmids of various sizes. e PFGE profiles were generated after restriction digestion of chromosomal DNA with SpeI and XbaI restriction enzymes. NC, nonclonal. were interpreted according to the guidelines of the National Committee for Clinical Laboratory Standards (22). The tablet disks contained the following antimicrobial agents: ampicillin, gentamicin, co-trimoxazole, amoxicillin-clavulanic acid, piperacillin-tazobactam, aztreonam, temocillin, ceftazidime, cefazolin, cefuroxime, ceftriaxone, imipenem, ciprofloxacin, and amikacin. Strains with intermediate zones were considered resistant. Plasmid profile analysis. Plasmid DNA of the 45 strains was prepared by the method described by Portnoy et al. (26). By this method, the lysis solution destroys the cell wall as well as the cell membrane and denatures the chromosomal DNA in a single step by the combined action of sodium dodecyl sulfate and an alkaline solution. The technique is based on the fact that a narrow ph range (ph to 12.55) can denature only the linear chromosomal DNA and not the covalently closed circular plasmid DNA. Plasmids were separated by electrophoresis run at 80 V for 4 h in a 0.7% agarose gel containing 1 TBE (Tris-borate-EDTA) buffer. The gels were stained in a 1- g/ml ethidium bromide solution, visualized under UV light, and photographed with a Polaroid camera. The sizes of the plasmids were determined by using as a standard Escherichia coli V517, which contains seven different plasmids (16). DNA macrorestriction and PFGE. Genomic DNA was prepared by a protocol devised from different methods published elsewhere (2, 17, 19, 30). Bacterial cells were grown in 5.0 ml of Trypticase soy broth at 37 C overnight in a shaking water bath with agitation, and the optical density at 600 nm was measured. The optical density at 600 nm was adjusted with sterile Trypticase soy broth so that it had a cell concentration of 10 9 CFU/ml. For each isolate, 100 l of the cell suspension was pelleted by centrifugation and washed with EET buffer (100 mm
3 1848 JALALUDDIN ET AL. J. CLIN. MICROBIOL. FIG. 1. PFGE fingerprints of 45 E. aerogenes isolates (1995) after digestion with the XbaI restriction enzyme (A) and the SpeI restriction enzyme (B). Lane FH54 to lane BG64, profile IA and profile IB (broadly clone I); lane FH51 to lane FH90, profiles IIA, IIB, and IIC (broadly, clone II); lane FH49 to lane FH77, unrelated strains (nonclonal); lanes M, molecular size markers (PFGE marker I, l ladder). sodium EDTA, 10 mm sodium EGTA, 10 mm Tris-HCl [ph 7.5]), and the pellet was resuspended in 100 ml of the same buffer, an equal volume of 2% melted InCert agarose (FMC Bio Products, Vallensbaek Strand, Denmark) was mixed in, and the mixture was dispensed into two wells of the plug mold. After solidification, the plugs were incubated at 37 C for 1 h in 500 ml of lysis solution (lysozyme, 1 mg/ml; Tris-HCl, 10 mm; NaCl, 50 mm; sodium deoxycholate, 0.2%; sodium-n-lauroylsarcosine, 0.5%) and washed once with T10E1 buffer (Tris-HCl, 10 mm; sodium EDTA, 1 mm [ph 7.5]). The agarose plugs were subsequently deproteinized in 500 ml of proteinase K solution (proteinase K, 1 mg/ml; EDTA, 100 mm [ph 8.0]; sodium deoxycholate, 0.2%; sodium-n-lauroylsarcosine, 1%) at 50 C overnight, and the protein digestion products were removed by washing the plugs six times for 30 min each time with 1.0 ml of T10E1 buffer. During the second wash 15 ml of phenylmethylsulfonyl fluoride (100 mm) was added to inactivate the residual proteinase K activity. The E. aerogenes plugs were digested with 25 U of SpeI restriction enzyme, and a duplicate set of plugs was also digested with 40 U of XbaI restriction enzyme according to the manufacturer s instructions. The resultant fragments were resolved in the CHEF DRII system (Bio-Rad, Nazareth, Belgium) with a 1% agarose gel prepared and run in 0.53 TBE buffer. The gels were run at 6 V/cm for 20 h at 14 C. The pulse time ramped from 5 to 15 s for 20 h for SpeI-restricted plugs and two linear ramps of 5 to 40 s for 12 h followed by 3 to 8 s for 8 h for XbaI-restricted plugs. The PFGE marker-i (Boehringer Mannheim, Brussels, Belgium) was used as a molecular size standard. The gels were stained with ethidium bromide (1 mg/ml) and photographed under UV light. The PFGE patterns were compared initially by visual comparison and were interpreted according to the guidelines of Tenover et al. (31). Patterns were considered indistinguishable if every band was shared, closely related if they differed from one another by only two or three clearly visible bands, and different if they differed by seven or more bands. With the Molecular Analyst Software Fingerprinting, version 1.0 (Bio-Rad, Richmond, Calif.), PFGE patterns were also compared and clustered into a dendrogram. RESULTS Bacterial strains. In this investigation, 45 E. aerogenes isolates originating from 33 hospitalized patients were available.
4 VOL. 36, 1998 MOLECULAR EPIDEMIOLOGY OF NOSOCOMIAL E. AEROGENES 1849 FIG. 2. Dendrogram generated from PFGE patterns of nosocomial E. aerogenes strains (n 45) by Molecular Analyst Software Fingerprinting, version 1.0. Major clones are designated with arabic numerals, and subtypes are indicated by letter suffixes. Clustering was done with the unweighted pair group method with arithmatic averages algorithm by using fine correlation on gel tracks. These patients represented 84.6% of the 39 hospitalized patients from whom the organism was recovered in the year Single isolates were obtained from 26 patients, two isolates were obtained from 4 patients, three isolates were obtained from 2 patients, four isolates were obtained from 1 patient, and one isolate was obtained from a heparin vial specimen (Table 1). Biotyping. Fourteen different biotypes were generated among the 45 E. aerogenes isolates on the basis of the formulated profile found after positive and negative reactions in different wells of the BBL crystal E/NF identification system. The biotypes were arbitrarily designated 1 to 14. In a few patients the biotypes differed among the strains according to the site of isolation (Table 1). Screening of environmental specimens. E. aerogenes was isolated from the heparin vial specimen only. No E. aerogenes was found in any of the other environmental specimens. Antibiotyping. E. aerogenes isolates were grouped into 11 different antibiotypes depending upon their susceptibilities to 14 different antimicrobial drugs. Almost all strains were resistant to ampicillin, cefazolin, and cefuroxime but were sensitive to gentamicin, temocillin, amikacin, and imipenem. The anti- Patient no. TABLE 2. Clinical features of the 33 patients infected or colonized with E. aerogenes strains in Saint-Pierre University Hospital in 1995 Unit or ward Patient age (yr) First isolation date (day-mo-yr) Source of isolation Colonization or infection Outcome 1 Geriatric Tracheal aspirate Pneumonia and urinary Death tract infection 2 Surgical ICU Blood Septicemia Death 3 Coronary care unit Blood Septicemia Recovered 4 Medical ICU Blood Pneumonia Death 5 Geriatric Decubitus ulcer Colonization Recovered 6 Medicine Tracheal aspirate Bronchopneumonia Recovered 7 Medical ICU Sputum peritoneal fluid Abdominal infection Recovered 8 Medical ICU Catheter Colonization Death 9 Surgical ICU Pleural fluid Pleural empyema Death 10 Medical ICU Sputum Pneumonia Recovered 11 Medical ICU Tracheal aspirate Pneumonia Death 12 Geriatric Wound swab urine Urinary tract infection Death 13 Medicine Sputum Colonization Recovered 14 Medical ICU Blood Ascites infection Death 15 Medical ICU Blood Septicemia Recovered 16 Geriatric Nasopharyngeal aspirate Pneumonia Death 17 Geriatric Decubitus ulcer urine Urinary tract infection Recovered 18 Surgical ICU Abdominal wound Abdominal infection Death 19 Medical ICU Tracheal aspirate Pneumonia Recovered 20 Recovery unit Tracheal aspirate Bronchitis Recovered 21 Geriatric Rectal swab Colonization Death 22 Surgery Abdominal liquid Abdominal infection Recovered 23 Medical ICU Tracheal aspirate Pneumonia Death 24 Medicine Sputum Colonization Recovered 25 Medical ICU Tracheal aspirate Pneumonia Death 26 Geriatric Urine Urinary tract infection Recovered 27 Recovery unit Decubitus ulcer Colonization Recovered 28 Medicine Tongue swab Colonization Recovered 29 Otorhinolaryngology Urine Colonization Recovered 30 Medical ICU Sputum Colonization Recovered 31 Medical ICU Sputum Colonization Recovered 32 Surgery Sputum Colonization Recovered 33 Recovery unit Urine Urinary tract infection Recovered
5 1850 JALALUDDIN ET AL. J. CLIN. MICROBIOL. FIG. 3. Incidence of E. aerogenes at Saint-Pierre University Hospital from January 1994 to December microbial resistance patterns were pooled, and it was found that 91 to 100% of the strains were resistant to ampicillin, cefazolin, and cefuroxime; 82 to 84% were resistant to cotrimoxazole, aztreonam, ceftazidime, and ciprofloxacin; 56% were resistant to ceftriaxone, 40% were resistant to piperacillin-tazobactam; 31% were resistant to amoxicillin-clavulanate; and 2% were resistant to temocillin. The antibiotypes are presented in Table 1. Plasmid profile analysis of E. aerogenes. Plasmids were found in 43 (96%) of the 45 E. aerogenes isolates. Only one strain (from patient 29) harbored five plasmids of different sizes, whereas the rest of the strains were grouped into three different profiles depending upon the sizes and the numbers of the plasmids. Profile A consists of a big (30 to 40 MDa) and a small (5 to 6 MDa) plasmid. A total of 29 (64%) strains belonged to this profile. Ten (22%) strains belonged to profile B, which contained a single plasmid of 5 to 6 MDa. Profile C was found for four strains (9%), which contained three plasmids (20 to 30, 15 to 20, and 5 to 6 MDa, respectively). The plasmid data are listed in Table 1. PFGE. All 45 strains were typeable, and the fingerprints generated with both SpeI and XbaI restriction endonucleases equally demonstrated that 36 (80%) strains were derived from a single clone, designated clone I. Six (13%) strains were closely related and were designated as being derived from clones IIa and IIb, and only three (7%) strains were found to be nonclonal. The XbaI-digested fragments were more easily interpretable than the SpeI-digested fragments (Fig. 1). The dendrogram generated from PFGE patterns gave similar information (Fig. 2). Primary analysis of the clinical data from colonized and infected patients. The 45 E. aerogenes isolates were recovered from 33 patients, of whom 22 (66.7%) were infected and 11 (33.3%) were considered colonized. Most of the patients were elderly, were suffering from chronic underlying diseases, and were hospitalized in either the medical or the surgical ICU. During their hospitalization, 13 patients died (crude mortality rate, 39%). The clinical features are presented in Table 2. DISCUSSION E. aerogenes is able to cause nosocomial infections, like other members of the family Enterobacteriaceae. In 1995, the incidence of E. aerogenes in our hospital was higher than those in the preceding and the following years (Fig. 3). Among the 33 patients, the ratio of colonization and infection (1:2), as well as the high crude mortality rate (39%) among the E. aerogenesinfected patients, led us to be particularly concerned so we studied the epidemiology of this bacterium. In our study, we found that E. aerogenes colonizations or infections were endemic in the year 1995 and continued to the following year (unpublished data). The first isolated strain belonging to clone I (80% of the total isolates) appeared in January and infected a 58-year-old patient in the geriatric unit. This patient was colonized after 8 days of hospitalization and developed pneumonia and subsequently a urinary tract infection. The second acquisition occurred in April and was of a nonclonal strain that infected a 70-year-old patient in the surgical ICU; the patient developed septicemia, followed by death. From July until December, we found a real nosocomial outbreak caused by the two major clonal groups, groups I and II (Table 2). Most of the acquisitions occurred among elderly patients admitted to the two ICUs and the geriatric unit or transferred among these units. In this period, patients were probably colonized or infected through patient-to-patient transmission, via hospital personnel, or from other unknown hospital devices or environmental sources. The cause of the disappearance of the predominant clonal strain (clone I) in the months of February until June is not known, but infection control measures were probably strictly maintained at that time. We analyzed some environmental specimens (n 43), but only one E. aerogenes isolate was recovered from a patient s heparin vial (strain 4 of patient 2) used for parenteral treatment. The E. aerogenes isolate from this source did not belong to the predominant clone I and had the same antibiotype, plasmid profile, and PFGE pattern as those of two other blood isolates of the same patient. This indicates that for this patient transmission occurred through the heparin vial, which could possibly have been contaminated by the hands of the hospital personnel. Epidemiologic typing of the bacterial strains is being performed by using phenotypic and genotypic techniques. Phenotypic techniques are insufficient for discriminating among the isolates of different Enterobacter spp. In the present investigation, we found 14 different biotypes and 11 antibiotypes among the 45 E. aerogenes isolates, and these typing patterns failed to give any particular association between the strains. It was evident, however, that most of the strains were resistant to ampicillin, co-trimoxazole, aztreonam, ceftazidime, cefazolin, cefuroxime, and ciprofloxacin. DNA-based techniques have successfully been applied to demonstrating the differences be-
6 VOL. 36, 1998 MOLECULAR EPIDEMIOLOGY OF NOSOCOMIAL E. AEROGENES 1851 tween E. aerogenes strains in several studies (7, 11, 12, 13). In this study, we compared the results of plasmid profiling and PFGE analysis for the typing of E. aerogenes strains and demonstrated that a single clone was present over a period of 1 year. Plasmid analysis has been used most widely as a molecular method for comparing nosocomial isolates. In our study, the strains were divided into two major profiles, whereas two strains did not contain any plasmid. Instability of the plasmid profiles caused by the acquisition or loss of the plasmids is a great disadvantage of this method. Nevertheless, we found a good correlation between plasmid profiling and the other DNA-based method that we used, i.e., PFGE. Furthermore, no correlation could be found between plasmid profiles and antibiotypes (Table 1). To date, PFGE is the most powerful method for the analysis of nosocomial isolates because of its high reproducibility and discriminatory power (18, 27). Until now it is recommended as the gold standard for defining a clone in various nosocomial bacterial populations. In the present study, we found that almost all strains were clonal and that 80% of all strains were derived from a single clone that caused infection or colonization throughout the year. We evaluated two low-frequencycleaving enzymes, SpeI and XbaI, and found that the results obtained with both enzymes were equally reproducible but that the results were more easily interpretable with XbaI-resolved fragments (Fig. 1A and B). Moreover, use of the XbaI restriction enzyme was more cost-effective than use of SpeI (about 1/10 the price of SpeI [GIBCO-BRL]). Our study emphasizes the value of molecular typing methods for detecting the clonalities of strains in the investigation of nosocomial outbreaks caused by E. aerogenes. In conclusion, we found that plasmid profiling and PFGE with XbaI and/or SpeI macrorestriction were both useful for the epidemiologic typing of nosocomial E. aerogenes isolates. In most cases both techniques provided the same information that differentiated the unrelated strains and identified nosocomial outbreak-related organisms. Plasmid profile analysis is faster and requires less expertise than the PFGE method. It is suggested that it can be used as a screening method, whereas PFGE is more confirmatory but requires the use of expensive instruments and more expertise. ACKNOWLEDGMENTS We thank George Zissis for critical review of the manuscript and Olivier Vandenberg and Van den Abbeele Rudy for providing clinical data and cooperation during the preparation of the manuscript. This work was supported in part by grants from the Vesalius Foundation (foundation for medical research) to Jeanne-Marie Devaster. REFERENCES 1. Arpin, C., C. Coze, A. M. Rogues, J. P. Gachie, C. Bebear, and C. Quentin Epidemiological study of an outbreak due to multidrug-resistant Enterobacter aerogenes in a medical intensive care unit. J. Clin. Microbiol. 34: Bio-Rad Laboratories. GenePath Group 3 Reagent Kit for use with Pseudomonas, Enterobacter. Catalog no Bio-Rad Laboratories, Nazareth, Belgium. 3. Chow, J. W., and D. M. Shlaes Imipenem resistance associated with the loss of a 40 KDa outer membrane protein of Enterobacter aerogenes. J. Antimicrob. Chemother. 28: Davin-Regli, A., D. Monnet, P. Saux, C. Bosi, R. Charrel, A. Barthelemy, and C. Bollet Molecular epidemiology of Enterobacter aerogenes acquisition: one-year prospective study in two intensive care units. J. Clin. Microbiol. 34: De Champs, C., C. Henquell, D. Guelon, D. Sirot, N. Gazuy, and J. Sirot Clinical and bacteriological study of nosocomial infections due to Enterobacter aerogenes resistant to imipenem. J. Clin. Microbiol. 31: De Champs, C., D. Guelon, D. Joyon, D. Sirot, M. Chanal, and J. Sirot Treatment of a meningitis due to Enterobacter aerogenes producing a derepressed cephalosporinase and a Klebsiella pneumoniae producing an extended-spectrum beta-lactamase. Infection 19: De Gheldre, Y., N. Maes, F. Rost, R. De Ryck, P. Clevenbergh, J. L. Vincent, and M. J. Struelens Molecular epidemiology of an outbreak of multidrug-resistant Enterobacter aerogenes infections and in vivo emergence of imipenem resistance. J. Clin. Microbiol. 35: Farmer, J. J., III Enterobacteriaceae: introduction and identification, p In P. R. Murray, E. J. Baron, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C. 9. Garner, J. S., W. R. Jarvis, T. G. Emori, T. C. Horan, and J. M. Hughes CDC definitions for nosocomial infections. Am. J. Infect. Control 16: Gaston, M. A Enterobacter: an emerging nosocomial pathogen. J. Hosp. Infect. 11: Georghiou, P. R., R. J. Hamill, C. E. Wright, J. Versalovic, T. Koeuth, D. A. Watson, and J. R. Lupski Molecular epidemiology of infections due to Enterobacter aerogenes: identification of hospital outbreak-associated strains by molecular techniques. Clin. Infect. Dis. 20: Grattard, F., B. Pozetto, L. Tabard, M. Petit, A. Ros, and O. G. Gaudin Characterization of nosocomial strains of Enterobacter aerogenes by arbitrarily primed PCR analysis and ribotyping. Infect. Control Hosp. Epidemiol. 16: Grattard, F., B. Pozzeto, P. H. Berthelot, P. Berthelot, I. Rayet, A. Ros, B. Lauras, and O. G. Gaudin Arbitrarily primed PCR, ribotyping, and plasmid pattern analysis applied to investigation of a nosocomial outbreak due to Enterobacter cloacae in a neonatal intensive care unit. J. Clin. Microbiol. 32: Hopkins, J. M., and K. J. Towner Enhanced resistance to cefotaxime and imipenem associated with outer membrane protein alterations in Enterobacter aerogenes. J. Antimicrob. Chemother. 25: a.Jalaluddin, S., J.-M. Devaster, R. Scheen, M. Gerard, and J.-P. Butzler Molecular epidemiological study of nosocomial infections caused by Enterobacter aerogenes in a Belgian hospital, abstr. L-24, p In Abstracts of the 97th General Meeting of the American Society for Microbiology American Society for Microbiology, Washington, D.C. 15. Lambert-Zechovsky, N., E. Bingen, E. Denamur, N. Brahimi, P. Brun, H. Mathieu, and J. Elion Molecular analysis provides evidence for the endogenous origin of bacteremia and meningitis due to Enterobacter cloacae in an infant. Clin. Infect. Dis. 15: Macrina, F. L., D. J. Kopecko, K. R. Jones, D. J. Ayers, and S. M. McCowen A multiple plasmid-containing Escherichia coli strain: conventional source of size reference plasmid molecules. Plasmid 1: Maslow, J., and M. E. Mulligan Epidemiologic typing systems. Infect. Control Hosp. Epidemiol. 17: Maslow, J. N., A. M. Slutsky, and R. D. Arbeit Application of pulsed field gel electrophoresis to molecular epidemiology, p In D. H. Persing, T. F. Smith, F. C. Tenover, and T. J. White (ed.), Diagnostic molecular microbiology: principles and applications. American Society for Microbiology, Washington, D.C. 19. Matushek, M. G., M. J. M. Bonten, and M. K. Hayden Rapid preparation of bacterial DNA for pulsed-field gel electrophoresis. J. Clin. Microbiol. 34: Mellencamp, M. A., J. S. Roccaforte, L. C. Preheim, C. C. Sanders, C. A. Anene, and M. J. Bittner Isolation of Enterobacter aerogenes susceptible to beta-lactam antibiotics despite high level beta-lactamase production. Eur. J. Clin. Microbiol. Infect. Dis. 9: Meyers, H. B., E. Fontanilla, and L. Mascola Risk factors for development of sepsis in an hospital outbreak of Enterobacter aerogenes. Am. J. Infect. Control 16: National Committee for Clinical Laboratory Standards Performance standards for antimicrobial disk susceptibility testing, 6th ed. M2A6. National Committee for Clinical Laboratory Standards, Wayne, Pa. 23. Neuwirth, C., E. Siebor, J. Lopez, A. Pechinot, and A. Kazmierzak Outbreak of TEM-24-producing Enterobacter aerogenes in an intensive care unit and dissemination of the extended-spectrum -lactamase to other members of the family Enterobacteriaceae. J. Clin. Microbiol. 34: Peele, D., J. Bradfield, W. Pryor, and S. Vore Comparison of identifications of human and animal source gram-negative bacteria by API 20E and Crystal E/NF systems. J. Clin. Microbiol. 35: Pitout, J. D. D., E. S. Moland, C. C. Sanders, K. S. Thomson, and S. R. Fitzsimmons Lactamases and detection of -lactam resistance in Enterobacter spp. Antimicrob. Agents Chemother. 41: Portnoy, D. A., S. L. Moseley, and S. Falkow Characterization of plasmids and plasmid-associated determinants of Yersinia enterocolitica pathogenesis. Infect. Immun. 31: Richard, V. G Molecular epidemiology of nosocomial infection: analysis of chromosomal restriction fragment patterns by pulsed-field gel electrophoresis. Infect. Control Hosp. Epidemiol. 14: Robinson, A., Y. S. McCarter, and J. Tetreault Comparison of crystal enteric/nonfermenter system, API 20E system, and Vitec automicrobic sys-
7 1852 JALALUDDIN ET AL. J. CLIN. MICROBIOL. tem for identification of gram-negative bacilli. J. Clin. Microbiol. 33: Sanders, W. E. J., and C. C. Sanders Enterobacter spp.: pathogens poised to flourish at the turn of the century. Clin. Microbiol. Rev. 10: Struelens, M. J., F. Rost, A. Deplano, A. Maas, V. Schwam, E. Serruys, and M. Cremer Pseudomonas aeruginosa and Enterobacteriaceae bacteremia after biliary endoscopy: an outbreak investigation using DNA macrorestriction analysis. Am. J. Med. 95: Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan Interpreting chromosomal DNA restriction patterns produced by pulsed field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33: Wauters, G., A. Boel, G. P. Voorn, J. Verhaegen, F. Meunier, M. Janssens, and L. Verbist Evaluation of a new identification system, Crystal Enteric/Non-Fermenter, for gram-negative bacilli. J. Clin. Microbiol. 33: World Health Organization Expert Committee on Biological Standardization. Requirements for antibiotic susceptibility tests. Requirements for Biological Substances No. 26. World Health Organization, Geneva, Switzerland.
Emergence of Enterobacter aerogenes as a major antibiotic-resistant nosocomial pathogen in Belgian hospitals
ORIGINAL ARTICLE Emergence of Enterobacter aerogenes as a major antibiotic-resistant nosocomial pathogen in Belgian hospitals Clin Microbiol Infect 1999; 5: 622-627 Olivier Ronveaux, Yves De Glzeldre,
More informationEnterobacter aerogenes
Enterobacter aerogenes Piagnerelli M 1, Carlier E 1, Deplano A 3, Lejeune P 1, Govaerts D 2 1 Departments of Intensive Care and 2 Microbiology, A. Vésale Hospital. 6110 Montigny-le-Tilleul. 3 Department
More informationKlebsiella pneumoniae 21 PCR
2011 11 TEM-132 ESBL Klebsiella pneumoniae 1) 2) 1) 1) 3) 2) 1) 2) 3) 19 6 27 22 10 20 2003 4 2004 11 95 ceftazidime (CAZ) Klebsiella pneumoniae 21 PCR b- (ESBL) PCR (PFGE) PCR bla TEM-132 PFGE 19 TEM-132
More informationA Norazah, S M Liew, A G M Kamel, Y T Koh, V K E Lim. O r i g i n a l A r t i c l e
Singapore Med J 2001 Vol 42(1) : 015-019 O r i g i n a l A r t i c l e DNA Fingerprinting of Methicillin-Resistant Staphylococcus Aureus by Pulsed-Field Gel Electrophoresis (PFGE): Comparison of Strains
More information1) 1) 1) 2) 2) (ICU) Key words: (ICU), ( ) 1 30 TEL: FAX: Vol. 17 No
2007 277 1) 1) 1) 2) 2) 3) 4) 5) 6) 1) 2) 3) 4) 5) 6) 18 10 17 19 8 20 16 7 1 (ICU) 20 2x 1.6 2.2 2SD 14 1 4 1 10 7 3 2 9 7.6; 95 2.37 24.62 6 4 5 1 DNA SpeI 9 2 A 7 B 2 A 3 B 1 ICU ICU 7 20 10 5 Key words:
More information(PFGE) Clostridium di$cile
2009 205 (PFGE) Clostridium di$cile 1) 3) 2) 2) 2) 2, 4) 5) 1) 2) 3) 4) 5) 21 5 22 21 8 31 2004 1 2008 12 5 Clostridium di$cile (C. di$cile) 340 248 A /B 141 (56.9) A /B 26 (10.5) A /B 81 (32.7) 136 (PFGE)
More informationPrevalence of Extended Spectrum -Lactamases In E.coli and Klebsiella spp. in a Tertiary Care Hospital
ISSN: 2319-7706 Volume 3 Number 10 (2014) pp. 474-478 http://www.ijcmas.com Original Research Article Prevalence of Extended Spectrum -Lactamases In E.coli and Klebsiella spp. in a Tertiary Care Hospital
More informationGuidance on screening and confirmation of carbapenem resistant Enterobacteriacae (CRE) December 12, 2011
Guidance on screening and confirmation of carbapenem resistant Enterobacteriacae (CRE) December 12, 2011 Objectives: To discuss the guidelines for detection of CRE in the laboratory setting. To review
More informationIn-House Standardization of Carba NP Test for Carbapenemase Detection in Gram Negative Bacteria
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 01 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.701.342
More informationAffinity of Doripenem and Comparators to Penicillin-Binding Proteins in Escherichia coli and ACCEPTED
AAC Accepts, published online ahead of print on February 00 Antimicrob. Agents Chemother. doi:./aac.01-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationMolecular characterisation of CTX-M-type extendedspectrum β-lactamases of Escherichia coli isolated from a Portuguese University Hospital
EJHP Science Volume 17 2011 Issue 3 P. 1-5 2011 Pharma Publishing and Media Europe. All rights reserved 1781-7595 25 www.ejhp.eu Molecular characterisation of CTX-M-type extendedspectrum β-lactamases of
More informationGUIDE TO INFECTION CONTROL IN THE HOSPITAL. Carbapenem-resistant Enterobacteriaceae
GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 47: Carbapenem-resistant Enterobacteriaceae Authors E-B Kruse, MD H. Wisplinghoff, MD Chapter Editor Michelle Doll, MD, MPH) Topic Outline Key Issue Known
More informationALERT. Clinical microbiology considerations related to the emergence of. New Delhi metallo beta lactamases (NDM 1) and Klebsiella
ALERT Clinical microbiology considerations related to the emergence of New Delhi metallo beta lactamases (NDM 1) and Klebsiella pneumoniae carbapenemases (KPC) amongst hospitalized patients in South Africa
More informationST11 KPC-2 Klebsiella pneumoniae detected in Taiwan
AAC Accepts, published online ahead of print on 30 January 2012 Antimicrob. Agents Chemother. doi:10.1128/aac.05576-11 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5
More informationPublic Health Surveillance for Multi Drug Resistant Organisms in Orange County
Public Health Surveillance for Multi Drug Resistant Organisms in Orange County Matt Zahn, MD Medical Director Epidemiology and Assessment Orange County Public Health Antimicrobial Mechanisms of Action
More informationDiscussion points CLSI M100 S19 Update. #1 format of tables has changed. #2 non susceptible category
Discussion points 2009 CLSI M100 S19 Update Nebraska Public Health Laboratory Changes most important to routine antimicrobial susceptibility testing. Documents available Janet Hindler discussion slide
More informationOvercoming the PosESBLities of Enterobacteriaceae Resistance
Overcoming the PosESBLities of Enterobacteriaceae Resistance Review of current treatment options Jamie Reed, PharmD Pharmacy Grand Rounds August 28, 2018 Rochester, MN 2018 MFMER slide-1 Disclosure No
More informationNavigating Through Current and Emerging Issues in Outbreaks
Navigating Through Current and Emerging Issues in Outbreaks 7th GCC Conference on Infection Prevention and Control December 1-3, 2013 Kuwait City, Kuwait William R. Jarvis, M.D. Jason and Jarvis Associates,
More informationAntibiotic Resistance Pattern of Blood and CSF Culture Isolates At NHLS Academic Laboratories (2005)
Antibiotic Resistance Pattern of Blood and CSF Culture Isolates At NHLS Academic Laboratories (2005) Streptococcus pneumoniae (SP) Blood Culture Isolates Penicillin intermediate Penicillin Cefotaxime 336
More informationEmergence of Klebsiella pneumoniae ST258 with KPC-2 in Hong Kong. Title. Ho, PL; Tse, CWS; Lai, EL; Lo, WU; Chow, KH
Title Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Hong Kong Author(s) Ho, PL; Tse, CWS; Lai, EL; Lo, WU; Chow, KH Citation International Journal Of Antimicrobial Agents, 2011, v. 37 n. 4, p.
More informationScreening and detection of carbapenemases
Screening and detection of carbapenemases For many isolates with carbapenemases the MICs of carbapenems are around the susceptible breakpoint making resistance difficult to detect - particularly with automated
More informationMulti-clonal origin of macrolide-resistant Mycoplasma pneumoniae isolates. determined by multiple-locus variable-number tandem-repeat analysis
JCM Accepts, published online ahead of print on 30 May 2012 J. Clin. Microbiol. doi:10.1128/jcm.00678-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Multi-clonal origin
More informationIn Vitro Susceptibility Pattern of Cephalosporin- Resistant Gram-Negative Bacteria
In Vitro Susceptibility Pattern of Cephalosporin- Resistant Gram-Negative Bacteria Warunee Punpanich MD*, Worraporn Tantichattanon MD**, Siriporn Wongwatcharapaiboon MD**, Vipa Treeratweeraphong BSc, MSc***
More informationTyping of ônh ôstaphylococcus epidermidis ôns ô Colonizing in Human Nares by Pulsed-Field Gel Electrophoresis
Microbiol. Immunol., 39(5), 315-319, 1995 Typing of ônh ôstaphylococcus epidermidis ôns ô Colonizing in Human Nares by Pulsed-Field Gel Electrophoresis Lan Hu*, Akiko Umeda, and Kazunobu Amako Department
More informationNONFERMENTING GRAM NEGATIVE RODS. April Abbott Deaconess Health System Evansville, IN
NONFERMENTING GRAM NEGATIVE RODS April Abbott Deaconess Health System Evansville, IN OBJECTIVES Discuss basic limitations to assessing carbapenem resistance in nonfermenting GNRs Discuss antimicrobial
More informationHOSPITAL INFECTION CONTROL
HOSPITAL INFECTION CONTROL Objectives To be able to define hospital acquired infections discuss the sources and routes of transmission of infections in a hospital describe methods of prevention and control
More informationInsert for Kit 98006/98010/ KPC/Metallo-B-Lactamase Confirm Kit KPC+MBL detection Kit KPC/MBL and OXA-48 Confirm Kit REVISION: DBV0034J
Insert for Kit 98006/98010/98015 KPC/Metallo-B-Lactamase Confirm Kit KPC+MBL detection Kit KPC/MBL and OXA-48 Confirm Kit REVISION: DBV0034J DATE OF ISSUE: 09.02.2017 LANGUAGE: English FOR IN VITRO DIAGNOSTIC
More informationThe revolving door between hospital and community: extended-spectrum beta-lactamaseproducing Escherichia coli in Dublin.
Royal College of Surgeons in Ireland e-publications@rcsi Clinical Microbiology Articles Department of Clinical Microbiology 1-7-2012 The revolving door between hospital and community: extended-spectrum
More information(DHA-1): Microbiologic and Clinical Implications
AAC Accepts, published online ahead of print on 20 September 2010 Antimicrob. Agents Chemother. doi:10.1128/aac.00083-10 Copyright 2010, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationEVALUATION OF METHODS FOR AMPC β-lactamase IN GRAM NEGATIVE CLINICAL ISOLATES FROM TERTIARY CARE HOSPITALS
Indian Journal of Medical Microbiology, (2005) 23 (2):120-124 Brief Communication EVALUATION OF METHODS FOR AMPC β-lactamase IN GRAM NEGATIVE CLINICAL ISOLATES FROM TERTIARY CARE HOSPITALS S Singhal, T
More informationJOURNAL OF CLINICAL MICROBIOLOGY, Sept. 1998, p Vol. 36, No. 9. Copyright 1998, American Society for Microbiology. All Rights Reserved.
JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 1998, p. 2575 2579 Vol. 36, No. 9 0095-1137/98/$04.00 0 Copyright 1998, American Society for Microbiology. All Rights Reserved. Can Results Obtained with Commercially
More informationFAECAL WELL D-ONE. System for the presumptive identification and antibiotic susceptibility of pathogenic microorganisms of the intestinal tract.
System for the presumptive identification and antibiotic susceptibility of pathogenic microorganisms of the intestinal tract. 1. INTRODUCTION Intestinal and gastrointestinal infections are a fairly common
More information10/4/16. mcr-1. Emerging Resistance Updates. Objectives. National Center for Emerging and Zoonotic Infectious Diseases. Alex Kallen, MD, MPH, FACP
National Center for Emerging and Zoonotic Infectious Diseases Emerging Resistance Updates Alex Kallen, MD, MPH, FACP Lead Antimicrobial Resistance and Emerging Pathogens Team Prevention and Response Branch
More informationEmergence of Multidrug Resistance in Ubiquitous and Dominant Pseudomonas aeruginosa Serogroup O:11
JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 1998, p. 897 901 Vol. 36, No. 4 0095-1137/98/$04.00 0 Copyright 1998, American Society for Microbiology Emergence of Multidrug Resistance in Ubiquitous and Dominant
More informationDetecting CRE. what does one need to do?
5 th ICAN Conference, Harare 4 th November 2014 Room 2: 10:30-12:00 Detecting CRE (Carbapenem-resistant Enterobacteriaceae) what does one need to do? Dr Nizam Damani Associate Medical Director Infection
More informationSurveillance of antimicrobial susceptibility of Enterobacteriaceae pathogens isolated from intensive care units and surgical units in Russia
Feb. 2016 THE JAPANESE JOURNAL OF ANTIBIOTICS 69 1 41 41 Surveillance of antimicrobial susceptibility of Enterobacteriaceae pathogens isolated from intensive care units and surgical units in Russia IRINA
More informationMolecular epidemiology and drug resistance mechanism of Salmonella species especially in S. Typhi strains isolated in Bangladesh
Molecular epidemiology and drug resistance mechanism of Salmonella species especially in S. Typhi strains isolated in Bangladesh Dr. Kaisar Ali Talukder Senior Scientist Icddr,b This presentation will
More informationPseudomonas aeruginosa
JOURNAL OF CLINICAL MICROBIOLOGY, July 1983, p. 16-164 95-1137/83/716-5$2./ Copyright C) 1983, American Society for Microbiology Vol. 18, No. 1 A Three-Year Study of Nosocomial Infections Associated with
More informationHelen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); July 2014.
Annual survey of extended-spectrum -lactamase (ESBL)-producing Enterobacteriaceae, 2013 Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory, Institute of Environmental Science and Research
More informationBlood culture 壢新醫院 病理檢驗科 陳啟清技術主任
Blood culture 壢新醫院 病理檢驗科 陳啟清技術主任 A Positive Blood Culture Clinically Important Organism Failure of host defenses to contain an infection at its primary focus Failure of the physician to effectively eradicate,
More informationSensitivity of Surveillance Testing for Multidrug-Resistant Gram-Negative Bacteria in the
JCM Accepts, published online ahead of print on 20 August 2014 J. Clin. Microbiol. doi:10.1128/jcm.02369-14 Copyright 2014, American Society for Microbiology. All Rights Reserved. 1 2 Sensitivity of Surveillance
More informationEpidemiology of the β-lactamase resistome among Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae in the Chicago region
Epidemiology of the β-lactamase resistome among Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae in the Chicago region Michael Y. Lin MD MPH 1, Karen Lolans BS 1, Rosie D. Lyles,
More informationUniversity of Alberta Hospital Antibiogram for 2007 and 2008 Division of Medical Microbiology Department of Laboratory Medicine and Pathology
University of Alberta Hospital Antibiogram for 2007 and 2008 Division of Medical Microbiology Department of Laboratory Medicine and Pathology This material is supported in part by unrestricted educational
More informationThe New England Journal of Medicine. Case Ascertainment
SURVEILLANCE FOR ESCHERICHIA COLI O157:H7 INFECTIONS IN MINNESOTA BY MOLECULAR SUBTYPING JEFFREY B. BENDER, D.V.M., M.S., CRAIG W. HEDBERG, PH.D., JOHN M. BESSER, M.S., DAVID J. BOXRUD, B.S., KRISTINE
More informationIn vitro assessment of dual drug combinations to inhibit growth of Neisseria gonorrhoeae
AAC Accepted Manuscript Posted Online 26 January 2015 Antimicrob. Agents Chemother. doi:10.1128/aac.04127-14 Copyright 2015, American Society for Microbiology. All Rights Reserved. 1 2 In vitro assessment
More informationImipenem Resistance of Enterobacter aerogenes Mediated by Outer Membrane Permeability
JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 2000, p. 1048 1052 Vol. 38, No. 3 0095-1137/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Imipenem Resistance of Enterobacter
More informationRapid identification of emerging resistance in Gram negatives. Prof. Patrice Nordmann
Rapid identification of emerging resistance in Gram negatives Prof. Patrice Nordmann Emerging Resistance threats, CDC USA-2013 Enterobacteriaceae producing extendedspectrum β-lactamases (ESBL) Multi-resistant
More informationRapid identification and resistance assessment: The future is mass spectrometry
Rapid identification and resistance assessment: The future is mass spectrometry Dr Sanmarié Schlebusch Director of Microbiology Mater Pathology Brisbane Outline Introduction Plug and play Pre-prep and
More informationExpert rules. for Gram-negatives
Academic Perspective in Expert rules Emerging Issues of Resistance in Gram-ve Bacteria for Gram-negatives Trevor Winstanley Sheffield Teaching Hospitals Presented on behalf of David Livermore University
More informationRevised AAC Version 2» New-Data Letter to the Editor ACCEPTED. Plasmid-Mediated Carbapenem-Hydrolyzing β-lactamase KPC-2 in
AAC Accepts, published online ahead of print on 3 December 2007 Antimicrob. Agents Chemother. doi:10.1128/aac.01180-07 Copyright 2007, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationDifferentiation of Carbapenemase producing Enterobacteriaceae by Triple disc Test
Original article: Differentiation of Carbapenemase producing Enterobacteriaceae by Triple disc Test Manish Bansal 1, Nitya Vyas 2, Babita Sharma 3, R.K.Maheshwari 4 1PG Resident, 2 Professor, 3 Assistant
More information(multidrug-resistant Pseudomonas aeruginosa; MDRP)
220 2009 (multidrug-resistant Pseudomonas aeruginosa; MDRP) 21 4 1 21 10 4 amikacin (AMK), imipenem/cilastatin (IPM), ciprofloxacin (CPFX) multidrug-resistant Pseudomonas aeruginosa (MDRP) CHROMagar TM
More informationPseudo-outbreak of extremely drug-resistant Pseudomonas. aeruginosa urinary tract infections due to contamination of the. automated urine analyzer
JCM Accepts, published online ahead of print on 4 January 2012 J. Clin. Microbiol. doi:10.1128/jcm.06268-11 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5 6 7 8 9 10
More informationCross-colonisation with Pseudomonas aeruginosa of patients in an intensive care unit
Thorax 1998;53:1053 1058 1053 Internal Medicine, University Hospital Maastricht, Maastricht, The DCJJBergmans S van der Geest R M Wilting P W de Leeuw Internal Medicine, University Hospital Utrecht, Utrecht,
More informationExtended-Spectrum -Lactamases: a Clinical Update
CLINICAL MICROBIOLOGY REVIEWS, Oct. 2005, p. 657 686 Vol. 18, No. 4 0893-8512/05/$08.00 0 doi:10.1128/cmr.18.4.657 686.2005 Copyright 2005, American Society for Microbiology. All Rights Reserved. Extended-Spectrum
More informationClinical and Bacteriological Study of Nosocomial Infections
JOURNAL OF CLIMCAL MICROBIOLOGY, Jan. 1993, p. 123-127 0095-1137/93/010123-05$02.00/0 Copyright ) 1993, American Society for Microbiology Vol. 31, No. 1 Clinical and Bacteriological Study of Nosocomial
More informationJournal of Infectious Diseases and
Journal of Infectious Diseases & Therapy ISSN: 2332-0877 Journal of Infectious Diseases and Therapy Santanirand et al., J Infect Dis Ther 2018, 6:5 DOI: 10.4172/2332-0877.1000378 Research Article Open
More informationLaboratory CLSI M100-S18 update. Paul D. Fey, Ph.D. Associate Professor/Associate Director Josh Rowland, M.T. (ASCP) State Training Coordinator
Nebraska Public Health Laboratory 2008 CLSI M100-S18 update Paul D. Fey, Ph.D. Associate Professor/Associate Director Josh Rowland, M.T. (ASCP) State Training Coordinator Agenda Discuss 2008 M100- S18
More informationStrain-specific transmission in an outbreak of ESBL-producing Enterobacteriaceae in the hemato-oncology care unit: a cohort study
Uemura et al. BMC Infectious Diseases (2017) 17:26 DOI 10.1186/s12879-016-2144-4 RESEARCH ARTICLE Open Access Strain-specific transmission in an outbreak of ESBL-producing Enterobacteriaceae in the hemato-oncology
More informationThe Occurrence of (MDR/MDS) Pseudomonas aeruginosa among Nosocomial and Community Acquired Infections in and around Coimbatore, India
ISSN: 2319-7706 Volume 4 Number 11 (2015) pp. 753-761 http://www.ijcmas.com Original Research Article The Occurrence of (MDR/MDS) Pseudomonas aeruginosa among Nosocomial and Community Acquired Infections
More informationDetection of NDM-1, VIM-1, KPC, OXA-48, and OXA-162 carbapenemases by MALDI- TOF mass spectrometry
JCM Accepts, published online ahead of print on 2 May 2012 J. Clin. Microbiol. doi:10.1128/jcm.01002-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5 6 7 8 9 10 11 12
More informationReport on susceptibility of Salmonella serotypes in Belgium Vicky Jasson
CODA-CERVA Report on susceptibility of Salmonella serotypes in Belgium 2014. Vicky Jasson Veterinary and Agrochemical Research Centre 1 Introduction Salmonella is one of the most important bacterial zoonotic
More informationExpert rules in antimicrobial susceptibility testing: State of the art
Expert rules in antimicrobial susceptibility testing: State of the art ESCMID Postgraduate Education Course Antimicrobial Susceptibility Testing and Surveillance: from Laboratory to Clinic Hospital Universitario
More informationChain of Infection Agent Mode of transmission Contact (direct, indirect, droplet spread) Airborne Common-vehicle spread Host
Goals Microbiology of Healthcare-associated Infections William A. Rutala, Ph.D., M.P.H. Director, Statewide Program for Infection Control and Epidemiology and Research Professor of Medicine, University
More informationDetermining the Optimal Carbapenem MIC that Distinguishes Carbapenemase-Producing
AAC Accepted Manuscript Posted Online 8 August 2016 Antimicrob. Agents Chemother. doi:10.1128/aac.00838-16 Copyright 2016, American Society for Microbiology. All Rights Reserved. 1 1 2 Determining the
More informationMultidrug-Resistant Pseudomonas aeruginosa: Risk Factors and Clinical Impact
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Jan. 2006, p. 43 48 Vol. 50, No. 1 0066-4804/06/$08.00 0 doi:10.1128/aac.50.1.43 48.2006 Copyright 2006, American Society for Microbiology. All Rights Reserved. Multidrug-Resistant
More informationAPPENDIX-I. The compositions of media used for the growth and differentiation of Pseudomonas aeruginosa are as follows:
APPENDIX-I The compositions of media used for the growth and differentiation of Pseudomonas aeruginosa are as follows: COMPOSITION OF DIFFERENT MEDIA STOCK CULTURE AGAR (AYERS AND JOHNSON AGAR) Gms/Litre
More informationInt.J.Curr.Microbiol.App.Sci (2014) 3(3):
ISSN: 2319-7706 Volume 3 Number 3 (2014) pp. 668-674 http://www.ijcmas.com Original Research Article Antibiotic resistant pattern of urinary tract infection causing Escherichia coli isolated from diabetic
More informationSevere β-lactam allergy. Alternative (use for mild-moderate β-lactam allergy) therapy
Recommended Empirical Antibiotic Regimens for MICU Patients Notes: The antibiotic regimens shown are general guidelines and should not replace clinical judgment. Always assess for antibiotic allergies.
More informationAAC Accepts, published online ahead of print on 13 October 2008 Antimicrob. Agents Chemother. doi: /aac
AAC Accepts, published online ahead of print on 13 October 2008 Antimicrob. Agents Chemother. doi:10.1128/aac.00931-08 Copyright 2008, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationFrom the labo to the ICU: Surveillance cultures in daily ICU practice. Pieter Depuydt MD PhD Dept. Intensive Care Ghent University Hospital
From the labo to the ICU: Surveillance cultures in daily ICU practice Pieter Depuydt MD PhD Dept. Intensive Care Ghent University Hospital Question 1: What is the current practice of surveillance cultures
More informationGerald W. Tannock, 1 Ing Soo Tiong, 2 Patricia Priest, 3 Karen Munro, 1 Corinda Taylor, 1 Alice Richardson 1 and Michael Schultz 2 INTRODUCTION
Journal of Medical Microbiology (2011), 60, 366 370 DOI 10.1099/jmm.0.025874-0 Testing probiotic strain Escherichia coli Nissle 1917 (Mutaflor) for its ability to reduce carriage of multidrug-resistant
More information/01/$ DOI: /JCM Copyright 2001, American Society for Microbiology. All Rights Reserved.
JOURNAL OF CLINICAL MICROBIOLOGY, Jan. 2001, p. 183 190 Vol. 39, No. 1 0095-1137/01/$04.00 0 DOI: 10.1128/JCM.39.1.183 190.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved. Contemporary
More informationA genomic dissection of travel associated ESBL producing Salmonella Typhi originating from the Philippines
A genomic dissection of travel associated ESBL producing Salmonella Typhi originating from the Philippines A one-off occurrence or threat to the effective treatment of typhoid fever? Rene S. Hendriksen,
More informationClinical Failure of Vancomycin Treatment of Staphylococcus aureus Infection in a Tertiary Care Hospital in Southern Brazil
224 BJID 2003; 7 (June) Clinical Failure of Vancomycin Treatment of Staphylococcus aureus Infection in a Tertiary Care Hospital in Southern Brazil Larissa Lutz, Adão Machado, Nadia Kuplich and Afonso Luís
More informationAgainst Aerobic Gram-Negative Bacilli
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Dec. 1979, p. 6-6 0066-0/79/1-06/05$0.00/0 Vol., No. 6 In Vitro Activity of LY17935, a New 1-Oxa Cephalosporin, Against Aerobic Gram-Negative Bacilli DENNIS G. DELGADO,
More informationDevelopment of a phenotypic method for fecal carriage detection of OXA-48-producing
JCM Accepts, published online ahead of print on 11 May 2011 J. Clin. Microbiol. doi:10.1128/jcm.00055-11 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationScreening of Carbapenem Resistant Enterobacteriaceae among Nosocomial Isolates: A Study from South India
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 4 (2017) pp. 460-465 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.604.053
More informationCarbapenem-resistant Escherichia coli and Klebsiella pneumoniae in Taiwan
Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae in Taiwan An Infection Control Emergency Speaker: L Kristopher Siu Principal Investigator Division of Infectious Diseases National Institute
More informationCarbapenemases in Enterobacteriaceae: Prof P. Nordmann Bicêtre hospital, South-Paris Med School
Carbapenemases in Enterobacteriaceae: 2012 Prof P. Nordmann Bicêtre hospital, South-Paris Med School March 21, 2012 Trends in Molecular Medecine NDM IMP OXA-48 KPC VIM ALERT VI M KPC KPC NDM I MP OXA-
More informationPROFESSOR PETER M. HAWKEY
Multi-drug resistant Escherichia coli PROFESSOR PETER M. HAWKEY School of Immunity and Infection College of Medical and Dental Sciences University of Birmingham Birmingham B15 2TT Health Protection Agency
More informationURINARY TRACT INFECTIONS 3 rd Y Med Students. Prof. Dr. Asem Shehabi Faculty of Medicine, University of Jordan
URINARY TRACT INFECTIONS 3 rd Y Med Students Prof. Dr. Asem Shehabi Faculty of Medicine, University of Jordan Urinary Tract Infections-1 Normal urine is sterile.. It contains fluids, salts, and waste products,
More informationMethicillin-Resistant Staphylococcus aureus (MRSA) S urveillance Report 2008 Background Methods
Methicillin-Resistant Staphylococcus aureus (MRSA) Surveillance Report 2008 Oregon Active Bacterial Core Surveillance (ABCs) Office of Disease Prevention & Epidemiology Oregon Department of Human Services
More informationUrinary Tract Infections: From Simple to Complex. Adriane N Irwin, MS, PharmD, BCACP Clinical Assistant Professor Ambulatory Care October 25, 2014
Urinary Tract Infections: From Simple to Complex Adriane N Irwin, MS, PharmD, BCACP Clinical Assistant Professor Ambulatory Care October 25, 2014 Learning Objectives Develop empiric antimicrobial treatment
More informationORIGINAL INVESTIGATION. Rapid Spread of Carbapenem-Resistant Klebsiella pneumoniae in New York City
ORIGINAL INVESTIGATION Rapid Spread of Carbapenem-Resistant Klebsiella pneumoniae in New York City A New Threat to Our Antibiotic Armamentarium Simona Bratu, MD; David Landman, MD; Robin Haag, RN; Rose
More informationHealthcare-associated infections acquired in intensive care units
SURVEILLANCE REPORT Annual Epidemiological Report for 2015 Healthcare-associated infections acquired in intensive care units Key facts In 2015, 11 788 (8.3%) of patients staying in an intensive care unit
More informationCephalosporin, Against Cephalosporin-Resistant Bacteria, and
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Nov. 1979, P. 59-553 Vol. 16, No. 5 66-/79/11-59/$2./ Antibacterial Activity of Ceftizoxime (FK 79), a New Cephalosporin, Against Cephalosporin-Resistant Bacteria,
More informationGuess or get it right?
Guess or get it right? Antimicrobial prescribing in the 21 st century Robert Masterton Traditional Treatment Paradigm Conservative start with workhorse antibiotics Reserve more potent drugs for non-responders
More informationPrevalence of ESBL producing enterobacteriaceae in diabetic foot ulcers
Original Research Article Prevalence of ESBL producing enterobacteriaceae in diabetic foot ulcers Anitha S 1*, Natarajan V 2 1 Post Graduate, 2 Professor and HOD Department of Microbiology, Rajah Muthiah
More informationWhole genome sequencing & new strain typing methods in IPC. Lyn Gilbert ACIPC conference Hobart, November 2015
Whole genome sequencing & new strain typing methods in IPC Lyn Gilbert ACIPC conference Hobart, November 2015 Why do strain typing? Evolution, population genetics, geographic distribution 2 Why strain
More informationENG MYCO WELL D- ONE REV. 1.UN 29/09/2016 REF. MS01283 REF. MS01321 (COMPLETE KIT)
ENG MYCO WELL D- ONE MYCO WELL D-ONE System for the presumptive identification and antimicrobial susceptibility test of urogenital mycoplasmas, Gardnerella vaginalis, Trichomonas vaginalis, Candida albicans
More informationEpidemiology and Successful Control of a Large Outbreak Due to Klebsiella pneumoniae Producing Extended- Spectrum -Lactamases
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Jan. 1998, p. 53 58 Vol. 42, No. 1 0066-4804/98/$04.00 0 Copyright 1998, American Society for Microbiology Epidemiology and Successful Control of a Large Outbreak
More informationCharacterization of community and hospital Staphylococcus aureus isolates in Southampton, UK
Journal of Medical Microbiology (2010), 59, 1084 1088 DOI 10.1099/jmm.0.018986-0 Characterization of community and hospital Staphylococcus aureus isolates in Southampton, UK S. M. Green, 1 P. Marsh, 1
More informationMesporin TM. Ceftriaxone sodium. Rapid onset, sustained action, for a broad spectrum of infections
Ceftriaxone sodium Rapid onset, sustained action, for a broad spectrum of infections 1, 2, 3 Antibiotic with a broad spectrum of activity Broad spectrum of activity against gram-positive* and gram-negative
More informationCarbapenem Disks on MacConkey agar as screening methods for the detection of. Carbapenem-Resistant Gram negative rods in stools.
JCM Accepts, published online ahead of print on 7 November 2012 J. Clin. Microbiol. doi:10.1128/jcm.02878-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Carbapenem Disks
More informationRapid detection of carbapenemase-producing Enterobacteriaceae from blood cultures
ORIGINAL ARTICLE BACTERIOLOGY Rapid detection of carbapenemase-producing Enterobacteriaceae from blood cultures L. Dortet 1,L.Brechard 1, L. Poirel 1,2 and P. Nordmann 1,2 1) Service de Bacteriologie-Virologie,
More informationActivity of Ceftolozane/Tazobactam Against a Broad Spectrum of Recent Clinical Anaerobic Isolates
AAC Accepts, published online ahead of print on 25 November 2013 Antimicrob. Agents Chemother. doi:10.1128/aac.02253-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. Activity
More information